Chapter 1. Executive Summary
Chapter 2. Scope of The Study
2.1. Market Definition
2.2. Scope of The Study
2.2.1. Objectives of Report
Chapter 3. Evolve BI Methodology
Chapter 4. Market Insights and Trends
4.1. Supply/ Value Chain Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitutes
4.2.5. Industry Rivalry
4.3. Impact of COVID-19 on Formulation Development Outsourcing Market
4.3.1. Impact on Market Size
4.3.2. End User Trend, Preferences and Budget Impact
4.3.3. Regulatory Framework/Government Policies
4.3.4. Key Players Strategy to Tackle Negative Impact
4.3.5. Opportunity Window
Chapter 5. Market Dynamics
5.1. Introduction
5.2. DRO Analysis
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Opportunities
Chapter 6. Global Formulation Development Outsourcing Market, By Services
6.1. Introduction
6.2. Pre formulation Services
6.3. Formulation optimization
Chapter 7. Global Formulation Development Outsourcing Market, By Dosage form
7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Topical
7.5. Inhaled
7.6. Others
Chapter 8. Global Formulation Development Outsourcing Market, By Application
8.1. Introduction
8.2. Genetic Disorders
8.3. Oncology
8.4. Neurology
8.5. Infectious Diseases
8.6. Respiratory
8.7. Others
Chapter 9. Global Formulation Development Outsourcing Market, By End Use
9.1. Introduction
9.2. Pharmaceutical and Biopharmaceutical Companies
9.3. Government and Academic Institutes
Chapter 10. Global Formulation Development Outsourcing Market, By Region
10.1. Introduction
10.2. North America
10.2.1. Introduction
10.2.2. Driving Factors, Opportunity Analyzed and Key Trends
10.2.3. Market Size and Forecast, By Country, 2020 - 2028
10.2.4. Market Size and Forecast, By Services, 2020 - 2028
10.2.5. Market Size and Forecast, By Dosage form, 2020 - 2028
10.2.6. Market Size and Forecast, By Application, 2020 – 2028
10.2.7. Market Size and Forecast, By End User, 2020 – 2028
10.2.8. US
10.2.8.1. Introduction
10.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
10.2.8.3. Market Size and Forecast, By Services, 2020 - 2028
10.2.8.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.2.8.5. Market Size and Forecast, By Application, 2020 – 2028
10.2.8.6. Market Size and Forecast, By End User, 2020 - 2028
10.2.9. Canada
10.2.9.1. Introduction
10.2.9.2. Driving Factors, Opportunity Analyzed and Key Trends
10.2.9.3. Market Size and Forecast, By Services, 2020 - 2028
10.2.9.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.2.9.5. Market Size and Forecast, By Application, 2020 – 2028
10.2.9.6. Market Size and Forecast, By End User, 2020 - 2028
10.3. Europe
10.3.1. Introduction
10.3.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.3. Market Size and Forecast, By Country, 2020 - 2028
10.3.4. Market Size and Forecast, By Services, 2020 - 2028
10.3.5. Market Size and Forecast, By Dosage form, 2020 - 2028
10.3.6. Market Size and Forecast, By Application, 2020 – 2028
10.3.7. Market Size and Forecast, By End User, 2020 – 2028
10.3.8. Germany
10.3.8.1. Introduction
10.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.8.3. Market Size and Forecast, By Services, 2020 - 2028
10.3.8.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.3.8.5. Market Size and Forecast, By Application, 2020 – 2028
10.3.8.6. Market Size and Forecast, By End User, 2020 - 2028
10.3.9. France
10.3.9.1. Introduction
10.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.9.3. Market Size and Forecast, By Services, 2020 - 2028
10.3.9.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.3.9.5. Market Size and Forecast, By Application, 2020 – 2028
10.3.9.6. Market Size and Forecast, By End User, 2020 - 2028
10.3.10. UK
10.3.10.1. Introduction
10.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.10.3. Market Size and Forecast, By Services, 2020 - 2028
10.3.10.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.3.10.5. Market Size and Forecast, By Application, 2020 – 2028
10.3.10.6. Market Size and Forecast, By End User, 2020 - 2028
10.3.11. Italy
10.3.11.1. Introduction
10.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.11.3. Market Size and Forecast, By Services, 2020 - 2028
10.3.11.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.3.11.5. Market Size and Forecast, By Application, 2020 – 2028
10.3.11.6. Market Size and Forecast, By End User, 2020 - 2028
10.3.12. Rest of Europe
10.3.12.1. Introduction
10.3.12.2. Driving Factors, Opportunity Analyzed and Key Trends
10.3.12.3. Market Size and Forecast, By Services, 2020 - 2028
10.3.12.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.3.12.5. Market Size and Forecast, By Application, 2020 – 2028
10.3.12.6. Market Size and Forecast, By End User, 2020 - 2028
10.4. Asia-Pacific
10.4.1. Introduction
10.4.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.3. Market Size and Forecast, By Country, 2020 - 2028
10.4.4. Market Size and Forecast, By Services, 2020 - 2028
10.4.5. Market Size and Forecast, By Dosage form, 2020 - 2028
10.4.6. Market Size and Forecast, By Application, 2020 – 2028
10.4.7. Market Size and Forecast, By End User, 2020 - 2028
10.4.8. China
10.4.8.1. Introduction
10.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.8.3. Market Size and Forecast, By Services, 2020 - 2028
10.4.8.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.4.8.5. Market Size and Forecast, By Application, 2020 – 2028
10.4.8.6. Market Size and Forecast, By End User, 2020 - 2028
10.4.9. India
10.4.9.1. Introduction
10.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.9.3. Market Size and Forecast, By Services, 2020 - 2028
10.4.9.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.4.9.5. Market Size and Forecast, By Application, 2020 – 2028
10.4.9.6. Market Size and Forecast, By End User, 2020 - 2028
10.4.10. Japan
10.4.10.1. Introduction
10.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.10.3. Market Size and Forecast, By Services, 2020 - 2028
10.4.10.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.4.10.5. Market Size and Forecast, By Application, 2020 – 2028
10.4.10.6. Market Size and Forecast, By End User, 2020 - 2028
10.4.11. South Korea
10.4.11.1. Introduction
10.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.11.3. Market Size and Forecast, By Services, 2020 - 2028
10.4.11.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.4.11.5. Market Size and Forecast, By Application, 2020 – 2028
10.4.11.6. Market Size and Forecast, By End User, 2020 - 2028
10.4.12. Rest of Asia-Pacific
10.4.12.1. Introduction
10.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
10.4.12.3. Market Size and Forecast, By Services, 2020 - 2028
10.4.12.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.4.12.5. Market Size and Forecast, By Application, 2020 – 2028
10.4.12.6. Market Size and Forecast, By End User, 2020 - 2028
10.5. Rest of The World (RoW)
10.5.1. Introduction
10.5.2. Driving Factors, Opportunity Analyzed and Key Trends
10.5.3. Market Size and Forecast, By Services, 2020 - 2028
10.5.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.5.5. Market Size and Forecast, By Application, 2020 – 2028
10.5.6. Market Size and Forecast, By End User, 2020 - 2028
10.5.7. Market Size and Forecast, By Region, 2020 - 2028
10.5.8. South America
10.5.8.1. Introduction
10.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
10.5.8.3. Market Size and Forecast, By Services, 2020 - 2028
10.5.8.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.5.8.5. Market Size and Forecast, By Application, 2020 – 2028
10.5.8.6. Market Size and Forecast, By End User, 2020 - 2028
10.5.9. Middle East & Africa
10.5.9.1. Introduction
10.5.9.2. Driving Factors, Opportunity Analyzed and Key Trends
10.5.9.3. Market Size and Forecast, By Services, 2020 - 2028
10.5.9.4. Market Size and Forecast, By Dosage form, 2020 - 2028
10.5.9.5. Market Size and Forecast, By Application, 2020 – 2028
10.5.9.6. Market Size and Forecast, By End User, 2020 - 2028
Chapter 11. Competitive Landscape
11.1. Introduction
11.2. Vendor Share Analysis, 2020/Key Players Positioning, 2020
Chapter 12. Company Profiles
12.1. AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED
12.1.1. Business Overview
12.1.2. Financial Analysis
12.1.3. Product Portfolio
12.1.4. Recent Development and Strategies Adopted
12.1.5. SWOT Analysis
12.2. IRISYS, INC.
12.2.1. Business Overview
12.2.2. Financial Analysis
12.2.3. Product Portfolio
12.2.4. Recent Development and Strategies Adopted
12.2.5. SWOT Analysis
12.3. CHARLES RIVER LABORATORIES INTERNATIONAL, INC
12.3.1. Business Overview
12.3.2. Financial Analysis
12.3.3. Product Portfolio
12.3.4. Recent Development and Strategies Adopted
12.3.5. SWOT Analysis
12.4. INTERTEK GROUP PLC
12.4.1. Business Overview
12.4.2. Financial Analysis
12.4.3. Product Portfolio
12.4.4. Recent Development and Strategies Adopted
12.4.5. SWOT Analysis
12.5. CATALENT, INC.
12.5.1. Business Overview
12.5.2. Financial Analysis
12.5.3. Product Portfolio
12.5.4. Recent Development and Strategies Adopted
12.5.5. SWOT Analysis
12.6. SYGENE INTERNATIONAL LIMITED
12.6.1. Business Overview
12.6.2. Financial Analysis
12.6.3. Product Portfolio
12.6.4. Recent Development and Strategies Adopted
12.6.5. SWOT Analysis
12.7. LABORATORY CORPORATION OF AMERICA HOLDINGS
12.7.1. Business Overview
12.7.2. Financial Analysis
12.7.3. Product Portfolio
12.7.4. Recent Development and Strategies Adopted
12.7.5. SWOT Analysis
12.8. PATHEON (THERMO FISHER SCIENTIFIC)
12.8.1. Business Overview
12.8.2. Financial Analysis
12.8.3. Product Portfolio
12.8.4. Recent Development and Strategies Adopted
12.8.5. SWOT Analysis
12.9. QUOTIENT SCIENCES
12.9.1. Business Overview
12.9.2. Financial Analysis
12.9.3. Product Portfolio
12.9.4. Recent Development and Strategies Adopted
12.9.5. SWOT Analysis
12.10. EMERGENT BISOLUTIONS INC.
12.10.1. Business Overview
12.10.2. Financial Analysis
12.10.3. Product Portfolio
12.10.4. Recent Development and Strategies Adopted
12.10.5. SWOT Analysis
Chapter 13. Key Takeaways